Jeuveau
| Chemical Name | prabotulinumtoxinA-xvfs |
| Dosage Form | Injectable (intramuscular; 100 units/vial) |
| Drug Class | Inhibitors |
| System | Musculoskeletal |
| Company | Evolus |
| Approval Year | 2019 |
Indication
- Jeuveau is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.